Preventive effects of Citrus reticulata essential oil on bleomycin-induced pulmonary fibrosis in rats and the mechanism

Journal of Chinese Integrative Medicine

Volumn 10, Issue 2, 2012, Pages 200-209

  Zhou, Xian Mei ^a   Zhao, Yang ^a   He, Cui Cui ^b   Li, Jian Xin ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Bleomycin; Essential oil; Human embryonic lung fibroblasts; Pericarpium citri reticulatae; Pulmonary fibrosis; Rats

Indexed keywords

ANTIFIBROTIC AGENT; CITRUS RETICULATA ESSENTIAL OIL; CONNECTIVE TISSUE GROWTH FACTOR; ESSENTIAL OIL; MALONALDEHYDE; MESSENGER RNA; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS LUNG; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; LUNG ALVEOLITIS; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG PARENCHYMA; MALE; MANDARIN; NONHUMAN; PROTEIN EXPRESSION; RAT; WEIGHT GAIN;

ANIMALS; BLEOMYCIN; CELL LINE; CITRUS; FIBROBLASTS; HUMANS; LUNG; MALE; OILS, VOLATILE; PLANT BARK; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84863120677     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20120211     Document Type: Article

References (27)

1. Han MK, Swigris J, Liu L, Bartholmai B, Murray S, Giardino N, Thompson B, Frederick M, Li D, Schwarz M, Limper A, Flaherty K, Martinez FJ. Gender influences Health-Related Quality of Life in IPF. Respir Med. 2010; 104(5): 724-730.
2. Agarwal R, Jindal SK. Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur J Intern Med. 2008; 19(4): 227-235.
3. Bringardner BD, Baran CP, Eubank TD, Marsh CB. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal. 2008; 10 (2): 287-301.
4. Harari S, Caminati A. IPF: new insight on pathogenesis and treatment. Allergy. 2010; 65(5): 537-553.
5. Parra ER, Kairalla RA, Ribeiro de Carvalho CR, Eher E, Capelozzi VL. Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration. 2007; 74(2): 159-169.
6. Dempsey DJ. Clinical review: Idiopathic pulmonary fibrosis - past, present and future. Respir Med. 2006; 100 (11): 1871-1885.
7. Gomer RH, Lupher ML Jr. Investigational approaches to therapies for idiopathic pulmonary fibrosis. Expert Opin Investig Drugs. 2010; 19(6): 737-745.
8. Yang J, Cui Y, Kolb M. How useful is traditional herbal medicine for pulmonary fibrosis? Respirology. 2009; 14(8): 1082-1091.
9. Jiang HD, Guan HS. MS80, a novel sulfated oligosaccharide, inhibits pulmonary fibrosis by targeting TGF- betal both in vitro and in vivo. Acta Pharmacol Sin. 2009; 30(7): 973-979.
10. Zhou XM, Zhang GC, Li JX, Hou J. Inhibitory effects of citrus extracts on the experimental pulmonary fibrosis. J Ethnopharmacol. 2007; 111(2): 255-264.
11. Zhou XM, Huang MM, He CC, Li JX. Inhibitory effects of citrus extracts on the experimental pulmonary fibrosis. J Ethnopharmacol. 2009; 126(1): 143-148.
12. Peterson JJ, Dwyer JT, Beecher GR, Bhagwat SA, Gebhardt SE, Haytowitz DB, Holden JM. Flavanones in oranges, tangerines (mandarins), tangors, and tangelos: a compilation and review of the data from the analytical literature. J Food Compost Anal. 2006; 19(Suppl): S66-S73.
13. Yu L, Li X, Liu S, Xu G, Liang Y. Comparative analysis of volatile constituents in Citrus reticulata Blanco using GC-MS and alternative moving window factor analysis. J Sep Sei. 2009; 32(20): 3457-3465.
14. Xu P. Comparison of pharmacological effects in water extract and essential oil of Citrus reticulata. Jiangxi Zhong Yi Xue Yuan Xue Bao. 1998; 10(4): 172-173. Chinese.
15. China Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (part one). 2005 ed. Beijing: Chemical Industry Press. 2005: 53. Chinese.
16. Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW, Crystal RG. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis. 1979; 120(4): 893-839.
17. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2): 351-358.
18. Oyanagui Y. Reevaluation of assay methods and establishment of kit for Superoxide dismutase activity. Anal Biochem. 1984; 142(2): 290-296.
19. Kohyama T, Yamauchi Y, Takizawa H, Itakura S, Kamitani S, Kato J, Nagase T. Clarithromycin inhibits fibroblast migration. Respir Med. 2008; 102(12): 1769-1776.
20. Chua F, Gauldie J, Laurent GJ. Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol. 2005; 33(1): 9-13.
21. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008; 40(3): 362-382.
22. Gharaee-Kermani M, Ullenbruch M, Phan SH. Animal models of pulmonary fibrosis. Methods Mol Med. 2005; 117: 251-259.
23. Gao F, Kinnula VL, Myllärniemi M, Oury TD. Extracellular Superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal. 2008; 10(2): 343-354.
24. Boyaci H, Maral H, Turan G, Basjyigit I, Dillioglugil MÖ, Yildiz F, Tugay M, Pala A, Ercin C. Effects of erdosteine on bleomycin-induced lung fibrosis in rats. Mol Cell Biochem. 2006; 281(1-2): 129-137.
25. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest. 1997; 99(6): 1313-1321.
26. Kothapalli D, Frazier KS, Welply A, Segarini PR, Grotendorst GR. Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ. 1997; 8(1): 61-68.
27. Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest. 2007; 132 (4): 1311-1321.